| L718Q mutation as new mechanism of acquired resistance to AZD9291 in EGFR-mutated NSCLC M Bersanelli, R Minari, P Bordi, L Gnetti, C Bozzetti, A Squadrilli, ... Journal of thoracic oncology 11 (10), e121-e123, 2016 | 176 | 2016 |
| Re-education of tumor-associated macrophages by CXCR2 blockade drives senescence and tumor inhibition in advanced prostate cancer D Di Mitri, M Mirenda, J Vasilevska, A Calcinotto, N Delaleu, A Revandkar, ... Cell reports 28 (8), 2156-2168. e5, 2019 | 169 | 2019 |
| Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps G Giordano, L Gnetti, C Merisio, M Melpignano Maturitas 56 (2), 190-197, 2007 | 115 | 2007 |
| Kidney biopsy findings in a critically ill COVID-19 patient with dialysis-dependent acute kidney injury: a case against “SARS-CoV-2 nephropathy” GM Rossi, M Delsante, FP Pilato, L Gnetti, L Gabrielli, G Rossini, MC Re, ... Kidney international reports 5 (7), 1100-1105, 2020 | 93 | 2020 |
| Lung toxicity in non–small-cell lung cancer patients exposed to ALK inhibitors: report of a peculiar case and systematic review of the literature B Pellegrino, F Facchinetti, P Bordi, M Silva, L Gnetti, M Tiseo Clinical Lung Cancer 19 (2), e151-e161, 2018 | 56 | 2018 |
| Pleural tuberculosis: medical thoracoscopy greatly increases the diagnostic accuracy AG Casalini, PA Mori, M Majori, M Anghinolfi, EM Silini, L Gnetti, F Motta, ... ERJ open research 4 (1), 2018 | 55 | 2018 |
| Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs) M Tiseo, A Damato, L Longo, F Barbieri, F Bertolini, A Stefani, M Migaldi, ... Lung Cancer 104, 24-30, 2017 | 47 | 2017 |
| Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence A Revandkar, ML Perciato, A Toso, A Alajati, J Chen, H Gerber, ... Nature communications 7 (1), 13719, 2016 | 47 | 2016 |
| From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC P Bordi, M Del Re, R Minari, E Rofi, S Buti, G Restante, A Squadrilli, ... Lung Cancer 131, 78-85, 2019 | 46 | 2019 |
| Oncocytic carcinoma of parotid gland: a case report with clinical, immunohistochemical and ultrastructural features G Giordano, M Gabrielli, L Gnetti, T Ferri World Journal of Surgical Oncology 4, 1-4, 2006 | 42 | 2006 |
| MicroRNA expression in malignant pleural mesothelioma and asbestosis: a pilot study P Mozzoni, L Ampollini, M Goldoni, R Alinovi, M Tiseo, L Gnetti, ... Disease Markers 2017 (1), 9645940, 2017 | 40 | 2017 |
| Concurrent acquired BRAF V600E mutation and MET amplification as resistance mechanism of first-line osimertinib treatment in a patient with EGFR-mutated NSCLC R Minari, P Bordi, S La Monica, A Squadrilli, A Leonetti, L Bottarelli, ... Journal of Thoracic Oncology 13 (6), e89-e91, 2018 | 39 | 2018 |
| Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) syndrome and carcinoid tumors with/without NECH: a clinicopathologic, radiologic, and immunomolecular … MC Mengoli, G Rossi, A Cavazza, R Franco, FZ Marino, M Migaldi, ... The American journal of surgical pathology 42 (5), 646-655, 2018 | 38 | 2018 |
| Gene mutations in small-cell lung cancer (SCLC): results of a panel of 6 genes in a cohort of Italian patients P Bordi, M Tiseo, F Barbieri, M Bavieri, G Sartori, A Marchetti, F Buttitta, ... Lung Cancer 86 (3), 324-328, 2014 | 38 | 2014 |
| Serous psammocarcinoma of the ovary: a case report and review of literature G Giordano, L Gnetti, M Milione, D Piccolo, P Soliani Gynecologic oncology 96 (1), 259-262, 2005 | 38 | 2005 |
| Phase II, open-label, single-arm, multicenter study to assess the activity and safety of alectinib as neoadjuvant treatment in surgically resectable stage III ALK-positive … A Leonetti, R Minari, L Boni, L Gnetti, M Verzè, L Ventura, L Musini, ... Clinical Lung Cancer 22 (5), 473-477, 2021 | 37 | 2021 |
| Human papilloma virus (HPV) status, p16INK4a, and p53 overexpression in epithelial malignant and borderline ovarian neoplasms G Giordano, C Azzoni, T D’Adda, A Rocco, L Gnetti, E Froio, C Merisio, ... Pathology-Research and Practice 204 (3), 163-174, 2008 | 36 | 2008 |
| Endometrial mucinous microglandular adenocarcinoma: morphologic, immunohistochemical features, and emphasis in the human papillomavirus status G Giordano, T D'Adda, L Gnetti, C Merisio, M Melpignano International journal of gynecological pathology 25 (1), 77-82, 2006 | 35 | 2006 |
| Small cell lung cancer transformation as a resistance mechanism to osimertinib in epidermal growth factor receptor-mutated lung adenocarcinoma: case report and literature review A Leonetti, R Minari, G Mazzaschi, L Gnetti, S La Monica, R Alfieri, ... Frontiers in Oncology 11, 642190, 2021 | 33 | 2021 |
| Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC G Mazzaschi, G Milanese, P Pagano, D Madeddu, L Gnetti, F Trentini, ... Lung Cancer 144, 30-39, 2020 | 33 | 2020 |
